搡老女人多毛老妇女中国,日韩亚洲欧美中文高清在线,人妻少妇一区二区三区,色妞色综合久久夜夜,日本熟妇xxxx

重組蛋白

產(chǎn)品名稱(chēng) 貨號(hào) 規(guī)格
Recombinant Anabaena variabilis Urease subunit gamma (ureA) CSB-YP663407BYN
CSB-EP663407BYN
CSB-BP663407BYN
CSB-MP663407BYN
CSB-EP663407BYN-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Anabaena variabilis Arginine--tRNA ligase (argS), partial CSB-YP663408BYN
CSB-EP663408BYN
CSB-BP663408BYN
CSB-MP663408BYN
CSB-EP663408BYN-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Anabaena variabilis Light-independent protochlorophyllide reductase subunit B (chlB), partial CSB-YP663409BYN
CSB-EP663409BYN
CSB-BP663409BYN
CSB-MP663409BYN
CSB-EP663409BYN-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Anabaena variabilis 1- (5-phosphoribosyl)-5-[ (5-phosphoribosylamino)methylideneamino] imidazole-4-carboxamide isomerase (hisA) CSB-YP663410BYN
CSB-EP663410BYN
CSB-BP663410BYN
CSB-MP663410BYN
CSB-EP663410BYN-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Anabaena variabilis DNA mismatch repair protein MutS (mutS), partial CSB-YP663411BYN
CSB-EP663411BYN
CSB-BP663411BYN
CSB-MP663411BYN
CSB-EP663411BYN-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Anabaena variabilis 6-phosphofructokinase (pfkA) CSB-YP663412BYN
CSB-EP663412BYN
CSB-BP663412BYN
CSB-MP663412BYN
CSB-EP663412BYN-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Anabaena variabilis Cell division protein SepF (sepF) CSB-YP663413BYN
CSB-EP663413BYN
CSB-BP663413BYN
CSB-MP663413BYN
CSB-EP663413BYN-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Anabaena variabilis Cobalamin synthase (cobS), partial CSB-YP663414BYN1
CSB-EP663414BYN1
CSB-BP663414BYN1
CSB-MP663414BYN1
CSB-EP663414BYN1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Anabaena variabilis Plastocyanin (petE) CSB-YP663415BYN
CSB-EP663415BYN
CSB-BP663415BYN
CSB-MP663415BYN
CSB-EP663415BYN-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Anabaena variabilis Bifunctional protein FolD (folD) CSB-YP663416BYN
CSB-EP663416BYN
CSB-BP663416BYN
CSB-MP663416BYN
CSB-EP663416BYN-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Anabaena variabilis ATP synthase subunit alpha (atpA), partial CSB-YP663417BYN
CSB-EP663417BYN
CSB-BP663417BYN
CSB-MP663417BYN
CSB-EP663417BYN-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Anabaena variabilis N- (5'-phosphoribosyl)anthranilate isomerase (trpF) CSB-YP663418BYN
CSB-EP663418BYN
CSB-BP663418BYN
CSB-MP663418BYN
CSB-EP663418BYN-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Anabaena variabilis Light-independent protochlorophyllide reductase iron-sulfur ATP-binding protein (chlL) CSB-YP663419BYN
CSB-EP663419BYN
CSB-BP663419BYN
CSB-MP663419BYN
CSB-EP663419BYN-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Anabaena variabilis Proline--tRNA ligase (proS), partial CSB-YP663420BYN
CSB-EP663420BYN
CSB-BP663420BYN
CSB-MP663420BYN
CSB-EP663420BYN-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Anabaena variabilis Histidine--tRNA ligase (hisS) CSB-YP663421BYN
CSB-EP663421BYN
CSB-BP663421BYN
CSB-MP663421BYN
CSB-EP663421BYN-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Anabaena variabilis Protein translocase subunit SecA (secA), partial CSB-YP663422BYN
CSB-EP663422BYN
CSB-BP663422BYN
CSB-MP663422BYN
CSB-EP663422BYN-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Anabaena variabilis 30S ribosomal protein S2 (rpsB) CSB-YP663423BYN
CSB-EP663423BYN
CSB-BP663423BYN
CSB-MP663423BYN
CSB-EP663423BYN-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Anabaena variabilis 50S ribosomal protein L25 (rplY) CSB-YP663424BYN
CSB-EP663424BYN
CSB-BP663424BYN
CSB-MP663424BYN
CSB-EP663424BYN-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Anabaena variabilis Thymidylate kinase (tmk) CSB-YP663425BYN
CSB-EP663425BYN
CSB-BP663425BYN
CSB-MP663425BYN
CSB-EP663425BYN-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Anabaena variabilis Ycf48-like protein (Ava_1856) CSB-YP663426BYN
CSB-EP663426BYN
CSB-BP663426BYN
CSB-MP663426BYN
CSB-EP663426BYN-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過(guò)多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開(kāi)發(fā)過(guò)程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長(zhǎng)度(全長(zhǎng)或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來(lái)自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開(kāi)發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來(lái)產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過(guò)多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過(guò)程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來(lái)選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對(duì)其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見(jiàn)問(wèn)題。您可以單擊以下鏈接查看。http://www.pptc.cn/technology-91.html。此外,我們還為我們的客戶(hù)提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對(duì)CUSABIO的蛋白質(zhì)有任何疑問(wèn),涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們?cè)诰€(xiàn)留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>